A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

Clinical trial NCT01394016 · COMPLETED

Trial details

NCT number: NCT01394016
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2009-12-07
Primary completion: 2014-05-29
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.